Boston Biomedica Sheds Diagnostics, Biotech Units To Focus On PCT System
This article was originally published in The Gray Sheet
Executive Summary
SeraCare Life Sciences' $30 mil. acquisition of Boston Biomedica, Inc.'s Biotech Research Laboratories and Diagnostics divisions is aimed at providing expanded services to diagnostics manufacturers